Form 4 Filing: Powell Michael Acquires Stock Options in Bicara Therapeutics Inc.

Michael Powell, a director at Bicara Therapeutics Inc. (BCAX), acquired 19,475 stock options on June 9, 2026. These options, with an exercise price of $20.56 per share, are for Bicara Therapeutics Inc. Common Stock. The underlying shares vest upon the earlier of June 9, 2027, or the next Annual Meeting of Stockholders, contingent on Powell's continued service. The options expire on June 9, 2036. This transaction is reported on Form 4.